Wanming Hu
Impact in
Papers in
- Co-authors
- Yuanzhong Yang (15 shared papers)Jing Zeng (16 shared papers)Wenzhuo He (11 shared papers)Chang Jiang (7 shared papers)Liangping Xia (6 shared papers)Lin Yang (6 shared papers)Pengfei Kong (5 shared papers)Qiankun Xie (5 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Journal of Translational Medicine (4 papers)Journal of Cancer (3 papers)Cancer Management and Research (3 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wanming Hu
74 papers receiving 984 citations
Peers
Comparison fields: 5 of 83
- Oncology 364
- Genetics 136
- Immunology 157
- Cancer Research 90
- Hepatology 36
Countries citing papers authored by Wanming Hu
This map shows the geographic impact of Wanming Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanming Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanming Hu more than expected).
Fields of papers citing papers by Wanming Hu
This network shows the impact of papers produced by Wanming Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanming Hu. The network helps show where Wanming Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanming Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 100 | |
| 2 | 2018 | 64 | |
| 3 | 2019 | 60 | |
| 4 | 2016 | 56 | |
| 5 | 2021 | 39 | |
| 6 | 2019 | 35 | |
| 7 | 2015 | 32 | |
| 8 | IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients. | 2020 | 32 |
| 9 | 2020 | 27 | |
| 10 | 2019 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2018 | 22 | |
| 13 | 2021 | 22 | |
| 14 | 2020 | 21 | |
| 15 | 2018 | 19 | |
| 16 | 2020 | 18 | |
| 17 | 2022 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2020 | 16 | |
| 20 | 2016 | 16 |
About Wanming Hu
Wanming Hu is a scholar working on Oncology, Genetics, Molecular Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 993 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Brain Metastases and Treatment (3 papers), AI in cancer detection (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Oncology (364 citations), Genetics (136 citations), Immunology (157 citations), Cancer Research (90 citations) and Hepatology (36 citations). Wanming Hu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuanzhong Yang, Jing Zeng, Wenzhuo He, Chang Jiang, Liangping Xia, Lin Yang, Pengfei Kong, Qiankun Xie, Ke Sai and Baihua Luo. Their work appears in journals such as Frontiers in Oncology, Journal of Translational Medicine, Journal of Cancer, Cancer Management and Research and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.